What is a high-alert medication?
A drug that carries a heightened risk of causing significant patient harm when used in error. The defining feature is the severity of the consequence, not how often the error happens.
Patient Safety
High-Alert Medications: The Drugs That Cause the Most Harm in an Error
By the RxReflex Content Team · Last reviewed August 6, 2026
High-alert medications are drugs that carry a heightened risk of causing significant patient harm when they are used in error. Errors with them are not necessarily more common — the consequences are more devastating. The list comes from ISMP, and Patient Safety & Quality Assurance is 23.75% of the 2026 PTCE.
What "high-alert" actually means
The phrase has a precise definition, and the exam uses it precisely. A high-alert medication is one where an error is disproportionately likely to seriously harm the patient. Frequency is not the criterion — severity is.
The list is maintained by the Institute for Safe Medication Practices (ISMP), now part of ECRI. The current acute-care list is the 2024 edition, which is organized as broad classes of medications plus a set of specific drugs. The 2024 revision added tranexamic acid injection.
fork_right
Three different lists
Don't confuse the three safety lists. High-alert = severe harm if an error occurs. LASA = names that look or sound alike, so the error is more likely. Do Not Use = abbreviations that cause misreadings. A drug can appear on more than one, and the exam will test whether you can tell them apart.
The six classes to know cold
| Class | The danger | Examples |
|---|---|---|
| Anticoagulants ("blood thinners") | Bleeding — warfarin needs INR monitoring | Warfarin, heparin, enoxaparin, apixaban |
| Insulin (all types) | Hypoglycemia — always verify the units; never share pens between patients | Glargine, lispro, aspart, regular |
| Opioids | Respiratory depression — confirm dose and route | Morphine, fentanyl, hydromorphone, oxycodone |
| Concentrated electrolytes | Never IV push undiluted — this can be fatal | Potassium chloride (KCl), hypertonic saline, magnesium sulfate |
| Methotrexate (non-oncology use) | Dosed weekly, not daily — daily dosing can be deadly | Oral methotrexate for RA or psoriasis |
| Neuromuscular blockers | Cause paralysis — the patient must be ventilated; label distinctly | Rocuronium, vecuronium, succinylcholine |
If you memorize nothing else from this page, memorize these six rows. They map onto a large share of the high-alert questions on the exam, and each one has exactly one headline danger.
Why each one is dangerous, in one line
- arrow_rightAnticoagulants — the therapeutic window is narrow and the failure mode is a bleed. Warfarin in particular interacts with an enormous number of drugs and foods.
- arrow_rightInsulin — a unit is a tiny quantity, and the abbreviation U is on the Do Not Use list precisely because it reads as a zero. "10U" misread as "100" is a tenfold overdose.
- arrow_rightOpioids — the same drug at the same number means very different things by different routes, and the failure mode is that the patient stops breathing.
- arrow_rightConcentrated electrolytes — these must be diluted. Concentrated potassium chloride given as an IV push is one of the classic fatal medication errors, which is why it is stocked and handled under restriction.
- arrow_rightMethotrexate — the weekly-versus-daily distinction is the entire risk. A patient taking a weekly rheumatoid-arthritis dose every day accumulates a toxic dose within a week.
- arrow_rightNeuromuscular blockers — they paralyze, including the muscles used to breathe. Given to a patient who is not ventilated, the outcome is immediate.
The safeguards the exam expects you to name
| Safeguard | What it looks like in practice |
|---|---|
| Limit access | Concentrated electrolytes and neuromuscular blockers are not kept in general floor stock |
| Independent double check | A second person verifies the drug, dose, and calculation independently — not by watching |
| Standardize | One concentration, one protocol for ordering, storing, preparing, and administering |
| Auxiliary labels | "Paralyzing agent," "weekly dosing," "must be diluted" |
| Bar-code scanning | Catches the wrong-product pull that reading the shelf does not |
| Tall Man lettering | For the high-alert drugs that are also look-alike names |
psychology_alt
A nuance worth knowing
ISMP's own guidance notes that a manual independent double check is not always the optimal strategy and is not practical for every drug on the list. "Double-check everything" is therefore not automatically the best answer — look for the safeguard that matches the specific failure mode in the question.
How this shows up on the PTCE
- arrow_right"Which of these is a high-alert medication?" — recognition, straight from the class list.
- arrow_right"What should the technician do FIRST?" — usually verify or escalate, never dispense.
- arrow_rightAuxiliary-label questions — which warning belongs on which drug.
- arrow_rightStorage and access questions — what may not sit in floor stock.
- arrow_rightThe methotrexate frequency trap — a prescription written for daily use when the indication calls for weekly.
- arrow_rightInsulin unit questions — where the Do Not Use list and the high-alert list intersect.
Notice how many of these are the same question in different clothing: something about this order does not match the drug's known failure mode — what do you do? The answer is almost always to stop and involve the pharmacist.
High-alert medications — FAQ
Who publishes the high-alert medication list?
The Institute for Safe Medication Practices (ISMP), now part of ECRI. The current acute-care list is the 2024 edition, organized as classes of medications plus specific drugs.
What are the main high-alert drug classes for the PTCB exam?
Anticoagulants, insulin, opioids, concentrated electrolytes, methotrexate for non-cancer use, and neuromuscular blockers. Each has one headline danger worth memorizing alongside the class.
Why is methotrexate a high-alert medication?
For rheumatoid arthritis and psoriasis it is dosed once weekly. Taken daily by mistake it accumulates to a toxic dose quickly, which is why weekly-dosing auxiliary labels exist.
What is the difference between high-alert and LASA drugs?
High-alert describes how badly an error hurts the patient. LASA — look-alike/sound-alike — describes how likely the error is because the names resemble each other. Some drugs are both.
Why can't concentrated potassium chloride be given IV push?
Undiluted concentrated potassium chloride given as a rapid IV push can cause fatal cardiac arrest. It must be diluted, and it is kept out of general floor stock for exactly that reason.
Patient Safety is nearly a quarter of the exam
The High-Alert Meds cheat sheet is one of the free sheets in RxReflex, and the app drills Patient Safety as realistic scenario questions — with a rationale for every option and watch-for notes on the mistakes technicians actually make. Free to start on iOS and Android.
Keep studying
LASA Drugs Cheat SheetThe look-alike/sound-alike pairs the exam loves — and how Tall Man letters keep them straight.
Controlled Substance SchedulesC-II to C-V rules, refill limits, and DEA forms — the law block that grew most in 2026.
How to Read a PrescriptionThe anatomy of an Rx, all ten DAW codes, and how to read an NDC off a stock bottle.Prefer a printable version? Grab “The PTCB Pass Code” free PDF — the highest-yield facts, formulas & traps on 22 pages.
Last reviewed August 6, 2026 by the RxReflex Content Team. Educational use only — not medical advice. Exam policies and fees are set by PTCB — always confirm details at ptcb.org. Verify clinical specifics with your pharmacist or a current label source such as DailyMed. RxReflex is not affiliated with or endorsed by the Pharmacy Technician Certification Board (PTCB).